Winner Medical Co., Ltd. (SHE:300888)
China
· Delayed Price · Currency is CNY 31.32
+0.35 (1.13%)
Apr 29, 2026, 11:15 AM CST
Winner Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 10,937 | 10,863 | 8,896 | 8,124 | 11,258 | 7,976 | Upgrade
|
| Other Revenue | 86.21 | 86.21 | 81.38 | 60.7 | 93.58 | 61.2 | Upgrade
|
| Revenue | 11,024 | 10,949 | 8,978 | 8,185 | 11,351 | 8,037 | Upgrade
|
| Revenue Growth (YoY) | 13.95% | 21.96% | 9.69% | -27.89% | 41.23% | -35.88% | Upgrade
|
| Cost of Revenue | 5,835 | 5,809 | 4,880 | 4,393 | 6,340 | 4,121 | Upgrade
|
| Gross Profit | 5,189 | 5,140 | 4,098 | 3,792 | 5,011 | 3,916 | Upgrade
|
| Selling, General & Admin | 3,507 | 3,479 | 2,931 | 2,756 | 2,649 | 2,444 | Upgrade
|
| Research & Development | 409.91 | 410.88 | 348.16 | 322.05 | 487.58 | 298.16 | Upgrade
|
| Other Operating Expenses | 54.33 | 53.64 | 26.2 | 39.96 | 98.09 | 65.39 | Upgrade
|
| Operating Expenses | 3,975 | 3,954 | 3,307 | 3,115 | 3,229 | 2,804 | Upgrade
|
| Operating Income | 1,214 | 1,187 | 790.81 | 677.12 | 1,782 | 1,113 | Upgrade
|
| Interest Expense | -52.08 | -55.11 | -54.86 | -63.44 | -50.04 | -29.99 | Upgrade
|
| Interest & Investment Income | 134.9 | 135.49 | 192.48 | 261.26 | 175.38 | 240.42 | Upgrade
|
| Currency Exchange Gain (Loss) | -28.61 | -28.61 | 40.19 | -7.63 | 52.07 | 0.61 | Upgrade
|
| Other Non Operating Income (Expenses) | -45.18 | -5.99 | -1.2 | 0.68 | -72.25 | -4.27 | Upgrade
|
| EBT Excluding Unusual Items | 1,223 | 1,232 | 967.43 | 867.99 | 1,887 | 1,319 | Upgrade
|
| Impairment of Goodwill | -179.04 | -179.04 | -90.74 | -188.79 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.38 | -24.34 | 2.86 | 46.68 | 32.15 | 58.47 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.53 | 0.55 | 5.88 | 32.2 | 3.73 | 3.25 | Upgrade
|
| Asset Writedown | -4.68 | -19.28 | -16.45 | -93.43 | -74.78 | -20.26 | Upgrade
|
| Other Unusual Items | 37.44 | 37.44 | 39.38 | 85.19 | 71.05 | 101.8 | Upgrade
|
| Pretax Income | 1,062 | 1,048 | 908.35 | 749.85 | 1,920 | 1,463 | Upgrade
|
| Income Tax Expense | 238.58 | 233.7 | 167.64 | 121.3 | 245.17 | 225.32 | Upgrade
|
| Earnings From Continuing Operations | 823.13 | 814.12 | 740.71 | 628.55 | 1,674 | 1,237 | Upgrade
|
| Minority Interest in Earnings | -52.24 | -46.15 | -45.33 | -48.14 | -23.62 | 1.88 | Upgrade
|
| Net Income | 770.89 | 767.97 | 695.38 | 580.4 | 1,651 | 1,239 | Upgrade
|
| Net Income to Common | 770.89 | 767.97 | 695.38 | 580.4 | 1,651 | 1,239 | Upgrade
|
| Net Income Growth | 1.23% | 10.44% | 19.81% | -64.84% | 33.20% | -67.47% | Upgrade
|
| Shares Outstanding (Basic) | 583 | 582 | 584 | 592 | 592 | 596 | Upgrade
|
| Shares Outstanding (Diluted) | 583 | 582 | 584 | 592 | 592 | 596 | Upgrade
|
| Shares Change (YoY) | 0.30% | -0.44% | -1.33% | 0.10% | -0.77% | 9.42% | Upgrade
|
| EPS (Basic) | 1.32 | 1.32 | 1.19 | 0.98 | 2.79 | 2.08 | Upgrade
|
| EPS (Diluted) | 1.32 | 1.32 | 1.19 | 0.98 | 2.79 | 2.08 | Upgrade
|
| EPS Growth | 0.93% | 10.92% | 21.43% | -64.88% | 34.23% | -70.28% | Upgrade
|
| Free Cash Flow | 997.62 | 1,018 | 364.87 | 310.26 | 1,784 | 128.42 | Upgrade
|
| Free Cash Flow Per Share | 1.71 | 1.75 | 0.62 | 0.52 | 3.02 | 0.21 | Upgrade
|
| Dividend Per Share | 0.750 | 0.750 | 0.650 | 0.500 | 1.357 | 0.900 | Upgrade
|
| Dividend Growth | 15.38% | 15.38% | 30.00% | -63.16% | 50.79% | -50.00% | Upgrade
|
| Gross Margin | 47.07% | 46.95% | 45.65% | 46.33% | 44.15% | 48.73% | Upgrade
|
| Operating Margin | 11.01% | 10.84% | 8.81% | 8.27% | 15.70% | 13.84% | Upgrade
|
| Profit Margin | 6.99% | 7.01% | 7.75% | 7.09% | 14.54% | 15.42% | Upgrade
|
| Free Cash Flow Margin | 9.05% | 9.29% | 4.06% | 3.79% | 15.72% | 1.60% | Upgrade
|
| EBITDA | 1,656 | 1,612 | 1,147 | 992.8 | 2,049 | 1,279 | Upgrade
|
| EBITDA Margin | 15.02% | 14.72% | 12.78% | 12.13% | 18.05% | 15.92% | Upgrade
|
| D&A For EBITDA | 442.42 | 425.2 | 356.32 | 315.68 | 266.49 | 166.69 | Upgrade
|
| EBIT | 1,214 | 1,187 | 790.81 | 677.12 | 1,782 | 1,113 | Upgrade
|
| EBIT Margin | 11.01% | 10.84% | 8.81% | 8.27% | 15.70% | 13.84% | Upgrade
|
| Effective Tax Rate | 22.47% | 22.30% | 18.46% | 16.18% | 12.77% | 15.40% | Upgrade
|
| Revenue as Reported | 11,024 | 10,949 | 8,978 | 8,185 | 11,351 | 8,037 | Upgrade
|
| Advertising Expenses | - | 1,093 | 816.38 | 651.82 | 600.16 | 692.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.